50 results
6-K
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
19 Sep 23
Report of Foreign Private Issuer
3:06pm
fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock
10-K
2022 FY
SCNI
Scinai Immunotherapeutics Ltd
17 Apr 23
Annual report
4:06pm
business.
Coverage and Reimbursement
Sales of any pharmaceutical product depend, in part, on the extent to which such product will be covered by third … , and the level of reimbursement for such product by third-party payors. Decisions regarding the extent of coverage and amount of reimbursement to be provided
6-K
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits
424B4
kqqhzw6o2f0xcsweupcy
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-1.1
vqgcbrt i8
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
e8uy34 ux3c3ga
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
6-K
EX-99.1
sj6t8l9f
10 Nov 22
Current Report
5:28pm
F-1
duty8mz1got51
29 Sep 22
Registration statement (foreign)
9:22am
6-K
EX-1.1
ld0 7c0su
29 Dec 21
Report of Foreign Private Issuer
6:06am
424B5
7lnr5v sfsbdc3c
28 Dec 21
Prospectus supplement for primary offering
5:20pm
424B5
i3ad8kovlx
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K
EX-99.1
mtwa56o3fbzy
22 Nov 21
Report of Foreign Private Issuer
6:05am
6-K
EX-99.1
c9t5kkrmyh7 gz
4 Mar 21
Report of Foreign Private Issuer
1:01pm